Canadian trends in liver cancer: A brief clinical and epidemiologic overview

Current Oncology

Volumn 20, Issue 1, 2013, Pages

  De, P ^a   Dryer, D ^b   Otterstatter, M C ^c   Semenciw, R ^a  

^a Societe canadienne du cancer   (Canada)

^b Prince Edward Island Cancer Treatment Centre   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Liver cancer; Prevention; Risk factors; Surveillance; Trends

Indexed keywords

ARTICLE; CANADA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; EPIDEMIOLOGICAL DATA; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; PREVALENCE; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; TREND STUDY;

EID: 84873425137     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.20.1190     Document Type: Article

References (35)

1. Ferlay J, Shin H, Bray F, et al. globocan 2008. Ver. 1.2. Cancer incidence and mortality worldwide: iarc CancerBase No. 10 [Web resource]. Lyon, France: International Agency for Research on Cancer; 2010. [Available at: http://globocan.iarc.fr; cited March 2, 2012]
2. World Health Organization (who). International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: who; 2000.
3. World Health Organization (who). International Classification of Diseases. 10th rev. Geneva, Switzerland: who; 1992.
4. Dyer Z, Peltekian K, van Zanten SV. Review article: the changing epidemiology of hepatocellular carcinoma in Canada. Aliment Pharmacol Ther 2005;22:17-22.
5. Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2012. Toronto, ON: Canadian Cancer Society; 2012.
6. Pocobelli G, Cook LS, Brant R, Lee SS. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis. Liver Int 2008;28:1272-1279.
7. Thomas MB, Zhu AX. Hepatocellular carcinoma: the need for progress. J Clin Oncol 2005;23:2892-2899.
8. Ellison LF, Wilkins K. An update on cancer survival. Health Rep 2010;21:55-60.
9. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42(suppl 3):S206-S214.
10. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15(suppl):E25-E30.
11. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
12. Lavanchy D, McMahon B. Worldwide prevalence and prevention of hepatitis C. In: Liang TJ, Hoofnagle JH, eds. Hepatitis C. San Diego, CA: Academic Press; 2000: 185-202.
13. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000;160:3227-3230.
14. Makimoto K, Higuchi S. Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men. Int J Epidemiol 1999;28:30-34.
15. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007;5:938-945,945.e1-4.
16. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005;42:218-224.
17. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM. Obesity and hepatocellular carcinoma. Gastroenterology 2004;127(suppl 1):S97-S103.
18. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006;4:369-380.
19. Zhu K, Moriarty C, Caplan LS, Levine RS. Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control 2007;18:315-321.
20. Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010;16:3603-3615.
21. De Vita VT, Rosenberg SA, Lawrence TS, eds. Cancer Principles and Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008.
22. Sherman M, Burak K, Maroun J, et al. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol 2011;18:228-240.
23. Weinbaum CM, Williams I, Mast EE, et al. On behalf of the Centers for Disease Control and Prevention (cdc). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57:1-20.
24. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 2010;51:729-733.
25. Smith BD, Morgan RL, Beckett GA, et al. On behalf of the Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012;61:1-32.
26. Pottie K, Greenaway C, Feightner J, et al. On behalf of the Canadian Collaboration for Immigrant and Refugee Health. Evidence-based clinical guidelines for immigrants and refugees. CMAJ 2011;183:E824-E925.
27. Sherman M, Shafran S, Burak K, et al. Management of chronic hepatitis B: consensus guidelines. Can J Gastroenterol 2007;21(suppl C):5C-24C.
28. United States, Department of Health and Human Services Office of Minority Health (omh). Chronic Hepatitis B in Asian Americans, Native Hawaiians and Other Pacific Islanders: Goals and Strategies [Web page]. Rockville, MD: omh; 2008. [Available at: http://minorityhealth.hhs.gov/templates/content.aspx?ID=7241&lvl=2&lvlID=190; cited September 19, 2012]
29. Ahmed F, Foster GR. Global hepatitis, migration and its impact on Western healthcare. Gut 2010;59:1009-1011.
30. Chen Y, Yi Q, Mao Y. Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002. Int J Health Geogr 2008;7:28.
31. Statistics Canada. Place of Birth, Generation Status, Citizenship and Immigration Reference Guide, 2006 Census. Cat. no. 97-557-GWE2006003. Ottawa, ON: Statistics Canada; 2006.
32. Citizenship and Immigration Canada (cic). Facts and Figures 2010: Immigration Overview, Permanent and Temporary Residents. Ottawa, ON: cic; 2011.
33. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011;15:223-243.
34. Center M M, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2011;20:2362-2368.
35. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;15(suppl 4):5-13.